Ruikang Pharmaceutical (002589.SZ) announced first-quarter results, net profit of 15.169 million yuan, a decrease of 28.31%

Ruikang Pharmaceutical (002589.SZ) released its report for the first quarter of 2024, achieving 20 operating income during the reporting period...

Zhitong FinanceApr 29 13:24

Ruikang Pharmaceutical (002589.SZ): 2023 pre-profit of 20 million yuan to 30 million yuan

Gelonghui, January 30 | Ruikang Pharmaceutical (002589.SZ) announced its 2023 annual results forecast. Net profit attributable to shareholders of listed companies during the reporting period was 20 million yuan to 30 million yuan, turning a year-on-year loss into a profit; net profit loss after deducting non-recurring profit and loss was 130 million yuan to 190 million yuan, a decrease of 79.52%-85.98% compared to the same period last year; basic earnings per share were 0.0133 yuan/share to 1990.00.0/share. The main reason why the 2023 results turned a loss into a profit compared to the same period of the previous year: the disposal of subsidiaries affects investment income and fair value

Gelonghui FinanceJan 30 06:50

Ruikang Pharmaceutical (002589.SZ) received a warning letter from the Shandong Securities Regulatory Bureau

Ruikang Pharmaceutical (002589.SZ) announced that the company received “On Ruikang Pharmaceutical Group Shares...” issued by the Shandong Securities Regulatory Bureau

Zhitong FinanceDec 29, 2023 06:18

Express News | Ruikang Pharmaceutical: Directors, supervisors and senior management team plan to increase the company's shares by 6 million yuan to 10 million yuan

BreakingsDec 24, 2023 04:17

Ruikang Pharmaceutical (002589.SZ): Directors, supervisors and senior management team plan to increase the company's shares by 6 million yuan to 10 million yuan

On December 22, Gelonghui Pharmaceutical (002589.SZ) announced that Ruikang Pharmaceutical (002589.SZ) announced that the company's directors, supervisors and senior management team plan to increase their holdings of the company's shares through centralized bidding on the Shenzhen Stock Exchange within 6 months from the date of disclosure of this announcement, with a total increase of not less than RMB 6 million and no more than RMB 10 million.

Gelonghui FinanceDec 22, 2023 07:34

Ruikang Pharmaceutical (002589.SZ) released first-half results, net profit of 306.673 million yuan, a year-on-year decrease of 48.01%

Ruikang Pharmaceutical (002589.SZ) released the 2023 semi-annual report, and the company's revenue was 4,080 billion yuan...

Zhitong FinanceAug 29, 2023 10:09